Empaone-L 10/5 Tablet

Empaone-L 10/5 Tablet is a prescription diabetes medicine that combines empagliflozin 10 mg and linagliptin 5 mg in each tablet. It belongs to two glucose-lowering classes: an SGLT2 inhibitor and a DPP-4 inhibitor. Empaone-L 10/5 Tablet is used along with diet and exercise to help improve blood sugar control in adults with type 2 diabetes. Some people may also benefit from its empagliflozin component when a clinician wants added support for heart and kidney risk reduction, depending on the full treatment plan.

How it works: Empagliflozin helps the kidneys pass extra glucose into the urine instead of keeping it in the blood. Linagliptin helps the body release more insulin after meals and lowers the amount of sugar the liver makes, and the tablet form provides both medicines in one dose.

Empaone-L 10/5 Tablet is the lower-strength sibling compared with Empaone-L 25/5 Tablet, so it is often chosen when a doctor wants the same linagliptin 5 mg dose with a smaller empagliflozin dose. That can make it a better fit for people who need blood sugar lowering but are not yet ready for the higher empagliflozin strength, or for those who are more sensitive to dehydration, low blood pressure, or urinary side effects.

• Type 2 diabetes blood sugar control
• Added treatment when one medicine is not enough
• May be part of a plan to support heart and kidney health in appropriate patients
• Taken with diet and exercise

• Swallow the tablet whole with water.
• Take it once daily at about the same time each day, unless your doctor tells you otherwise.
• It can be taken with or without food.
• Do not split, crush, or chew the tablet.
• Drink enough fluids, especially in hot weather or if you are exercising.
• If you miss a dose, take it when you remember unless it is almost time for the next dose; do not double up.

Each Empaone-L 10/5 Tablet provides empagliflozin 10 mg plus linagliptin 5 mg per tablet. The usual schedule is one tablet by mouth once daily, and the maximum is generally one tablet in 24 hours unless your prescriber gives different instructions. Your doctor decides whether this strength is appropriate, especially if you are being moved up from a lower dose or if the higher Empaone-L 25/5 Tablet is not needed.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Empagliflozin + Linagliptin may include:

• Urinary tract infection
• Genital yeast infection or itching
• More urination
• Thirst or dry mouth
• Nasal congestion or sore throat
• Mild nausea or stomach upset
• Low blood sugar when used with insulin or a sulfonylurea

• This is a prescription medicine for adults with type 2 diabetes, not a substitute for insulin in type 1 diabetes.
• Empaone-L 10/5 Tablet can raise the risk of dehydration and low blood pressure, especially in older adults or people on diuretics.
• Call your doctor before surgery or if you will not be eating or drinking normally, because the medicine may need to be held.
• Alcohol can increase the chance of dehydration and low blood sugar.
• Use caution if you have kidney problems, recurrent urinary infections, or a history of genital yeast infections.
• If you take insulin or a sulfonylurea, your low blood sugar risk may be higher.
• Tell your clinician if you have symptoms of pancreatitis, severe nausea, or severe abdominal pain.

• Insulin and sulfonylureas may increase low blood sugar risk.
• Diuretics can worsen dehydration and low blood pressure.
• Rifampin and certain other medicines may reduce linagliptin levels.
• Other diabetes medicines may need adjustment to avoid hypoglycemia.
• Medications that affect kidney function can increase safety concerns and should be reviewed.

Store Empaone-L 10/5 Tablet at room temperature in the original strip, away from moisture and excess heat.